Den 5/1-2026 kommer GUPEA att vara otillgängligt för alla under hela dagen.
Search
Now showing items 1-10 of 14
Novel cerebrospinal fluid and blood tau biomarkers in Alzheimer's disease and other neurodegenerative diseases
(2022-03-18)
Tau is a protein predominantly expressed in neurons in the central nervous system (CNS), where it binds microtubules (MT), playing a major role regulating their dynamics and architecture. Under pathological conditions, tau ...
Diagnostic, Prognostic, and Disease Activity Biomarkers in Multiple Sclerosis
(2023-03-15)
Multiple sclerosis (MS) is the most common immune-mediated disease of the central nervous system. While benign cases exist, if left untreated, MS results in the compounding accumulation of disability. In the last two ...
New Risk Factors in Poststroke Epilepsy
(2022-05-04)
The overall aim of the present research was to identify new risk factors for poststroke epilepsy (PSE). Specifically, we wanted to assess the impact of having a first-degree relative with epilepsy on PSE risk (Paper I), ...
Cerebrospinal fluid peptidomics: discovery of endogenous peptides as biomarkers of Alzheimer's disease
(2018-10-02)
Neurodegenerative diseases (NDs), the most prominent example of which is Alzheimer’s disease (AD), has turned out to be among the greatest challenges for modern medicine. Common characteristics of NDs involve the aggregation ...
Factors related to depression in women - over the life course
(2012-10-08)
FACTORS RELATED TO DEPRESSION IN WOMEN – OVER THE LIFE COURSE
Pia Gudmundsson Neuropsychiatric Epidemiology Unit, Department of ...
Biomarkers for Alzheimer's disease and the APOE polymorphism
(2019-04-18)
Alzheimer’s disease (AD) is the most common form of dementia and cerebrospinal fluid (CSF) biomarkers reflecting the core pathology of AD are now widely used for diagnosis making, in particular β-amyloid[1-42] (Aβ42) ...
Candidate biomarkers for synaptic pathology: neurogranin, neuroligins and neurexins in neurodegenerative disorders
(2021-05-14)
Synapses are small units through which neurons communicate in the brain. They represent the site of memory formation and cognitive abilities and are thus primarily affected by neurodegenerative diseases such as Alzheimer’s ...
Biochemical markers in dementia - Exploring Swedish registry data and the human proteome
(2019-09-04)
Cerebrospinal fluid (CSF) biomarkers of neurodegenerative diseases have a wide scope of applications in diagnostics, prognosis assessment, disease staging, treatment evaluation and more. In this PhD project we aimed to ...
Blood biomarkers for traumatic brain injury
(2015-11-13)
Traumatic brain injury (TBI) is the major cause of death and disability following blunt head trauma. The term mild TBI (mTBI) or concussion are used interchangeably in the literature. Concussion or mTBI is recognized as a ...
Guillian-Barré syndrome: Epidemiology and biomarkers in blood and cerebrospinal fluid
(2025-04-15)
Guillain-Barré syndrome (GBS) is a rare, potentially life-threatening disease. The incidence of GBS varies, and clusters can occur related to the increased prevalence of triggering events. Most patients recover well, but ...